(R)-1,1-dimethylethyl 6-cyano-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3oxohexanoate | 125971-92-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 酮酸及其衍生物
• 英文名称: (R)-1,1-dimethylethyl 6-cyano-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3oxohexanoate
• 英文别名: Hexanoic acid, 6-cyano-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-oxo-, 1,1-dimethylethyl ester, (R)-(9CI)；tert-butyl (5R)-5-[tert-butyl(dimethyl)silyl]oxy-6-cyano-3-oxohexanoate
• CAS: 125971-92-8
• 化学式: C₁₇H₃₁NO₄Si
• 分子量: 341.523
• InChiKey: DWVVSGIRDGZMPU-CQSZACIVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.98
• 重原子数：
  23
• 可旋转键数：
  10
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  76.4
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (R)-1,1-dimethylethyl 6-cyano-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3oxohexanoate 在 四丁基氟化铵 、 溶剂黄146 作用下， 以 四氢呋喃 为溶剂， 生成 (R)-3-氧代-5-羟基-6-氰基己酸叔丁酯
  参考文献：
  名称：

  （4R-顺式）-1,1-二甲基乙基6-氰基甲基-2,2-二甲基-1,3-二恶烷-4-乙酸酯的合成，这是制备强效组织CI-981的关键中间体HMG-CoA还原酶的选择性抑制剂

  摘要：

  描述了三种合成光学活性庚酸酯的替代方法（6），庚酸酯是制备高效和组织选择性HMG Co-A还原酶抑制剂的关键中间体。

  DOI：

  10.1016/s0040-4039(00)74189-x
• 作为产物：
  描述：

  3-[Tert-butyl(dimethyl)silyl]oxy-4-cyanobutanoic acid 生成 (R)-1,1-dimethylethyl 6-cyano-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3oxohexanoate
  参考文献：
  名称：

  Tetrahedron Lett. 1992, 33, 2279-2282

  摘要：

  DOI：

文献信息

• Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one
  申请人：Warner-Lambert Company

  公开号：US05003080A1

  公开（公告）日：1991-03-26

  An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien-4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans-(.+-.)-5-(4-fluorophenyl)-2-(1-methylethyl)-N-4-diphenyl-1-[2-tetrah ydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide by a novel synthesis where 4-methyl-3-oxo-N-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-.alpha.-[2-methyl-1-oxopropyl]-.gamma.-oxo-N,.beta.-diphenylbenze nebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahy dro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.

  本文描述了一种改进的方法，通过新型合成将1,6-庚二烯-4-醇转化为所需产物，以制备转-6-[2-(取代吡咯-1-基)烷基]吡喃-2-酮，共进行了八次操作。此外，还描述了一种改进的方法，通过新型合成将4-甲基-3-氧代-N-苯基戊酰胺转化为所需产物，或者通过一步反应将4-氟-α-[2-甲基-1-氧代丙基]-γ-氧代-N，β-二苯基苯基丁酰胺转化为所需产物，以制备(2R-转)和转-(+/-)-5-(4-氟苯基)-2-(1-甲基乙基)-N-4-二苯基-1-[2-四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺，以及从(R)-4-氰基-3-[[(1,1-二甲基乙基)二甲基硅氧基]丁酸制备(2R-转)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺，以及用于该过程的其他有价值的中间体。
• Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one
  申请人：Warner-Lambert Company

  公开号：US05149837A1

  公开（公告）日：1992-09-22

  An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien-4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans-(.+-.)-5-(4-fluoro-phenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetr ahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide by a novel synthesis where 4-methyl-3-oxo-N-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-.alpha.-[2-methyl-1-oxopropyl]-.gamma.-oxo-N,.beta.-diphenylbenze nebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahy dro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.

  本文介绍了一种改进的方法，通过新的合成方法将1,6-庚二烯-4-醇转化为所需产物，制备了转-6-[2-(取代吡咯-1-基)烷基]吡喃-2-酮，共进行了八个步骤。此外，还介绍了一种改进的方法，通过新的合成方法将4-甲基-3-氧代-N-苯基戊酰胺转化为所需产物，或者通过一步将4-氟-α-[2-甲基-1-氧代丙基]-γ-氧代-N，β-二苯基苯丁酰胺转化为所需产物，制备了(2R-转)和转-(.+-.)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺。此外，还介绍了一种从(R)-4-氰基-3-[[(1,1-二甲基乙基)二甲基硅氧基]丁酸制备(2R-转)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺的方法，以及用于该过程的其他有价值的中间体。
• Process for trans-6-[12-(substituted-pyrrol-1-yl)alkyl]pyran-2-one
  申请人：Warner-Lambert Co.

  公开号：US05216174A1

  公开（公告）日：1993-06-01

  An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans-(.+-.)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetra hydro4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3carboxamide by a novel synthesis where 4-methyl-3-oxoN-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-.alpha.-[2methyl-1-oxopropyl]-.gamma.-oxo-N,.beta.-diphenylbenzen ebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahy dro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1Hpyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.

  本文描述了一种改进的方法，通过新型合成将1,6-庚二烯-4-醇转化为所需产物，制备了转-6-[2-(取代吡咯-1-基)烷基]吡喃-2-酮，共进行了八个操作。此外，还描述了一种改进的方法，通过新型合成将4-甲基-3-氧代N-苯基戊酰胺转化为所需产物，或者通过一步将4-氟-α-[2-甲基-1-氧代丙基]-γ-氧代-N，β-二苯基苯丁烷酰胺转化为所需产物，制备了(2R-转型)和转型-(±)-5-(4-氟苯基)-2-(1-甲基乙基)-N，4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺。此外，还提供了一种从(R)-4-氰基-3-[[(1,1-二甲基乙基)二甲基硅氧基]丁酸制备(2R-转型)-5-(4-氟苯基)-2-(1-甲基乙基)-N，4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡咯-2-基)乙基]-1H-吡咯-3-羧酰胺的方法，以及用于制备这些化合物的其他有价值的中间体。
• Process for trans-6-(2-substituted-pyrrol-1-yl)alkyl)pyran-2-one
  申请人：Warner-Lambert Company

  公开号：US05124482A1

  公开（公告）日：1992-06-23

  An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien-4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans(.+-.)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrah ydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide by a novel synthesis where 4-methyl-3-oxo-N-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-.alpha.-[2-methyl-1-oxopropyl]-.gamma.-oxo-N,.beta.-diphenylbenze nebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahy dro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.

  本发明描述了一种改进的方法，通过一种新的合成方法，将1,6-庚二烯-4-醇转化为所需的产物，从而制备出改良的转-6-[2-(取代吡咯-1-基)烷基]吡喃-2-酮。此外，本发明还描述了一种改进的方法，通过一种新的合成方法，将4-甲基-3-氧代-N-苯基戊酰胺在八个步骤中转化为所需的产物，或者将4-氟-α-[2-甲基-1-氧代丙基]-γ-氧代-N，β-二苯基苯基丁酰胺在一步中转化为所需的产物，用于制备(2R-转)-5-(4-氟苯基)-2-(1-甲基乙基)-N，4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺，以及用于该过程中使用的其他有价值的中间体。此外，本发明还描述了一种从(R)-4-氰基-3-[[(1,1-二甲基乙基)二甲基硅氧基]丁酸制备(2R-转)-5-(4-氟苯基)-2-(1-甲基乙基)-N，4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺的方法。
• Tetrahedron Lett. 1992, 33, 2279-2282
  作者：

  DOI：——

  日期：——